Loading organizations...
§ Venture Capital · DE, USA
Private equity investment fund focusing on industry, with no publicly available details on operations, headquarters, or business model.
GSM Fund is an organization for which comprehensive public information regarding its core operations, headquarters, and business model remains undisclosed. Despite thorough research, no distinct entity matching 'GSM Fund' with a publicly accessible profile could be identified, precluding the ability to detail its specific activities or geographic base. As a result, key financial and operational metrics, such as assets under management, total funding raised, valuation, employee count, or user base, cannot be ascertained or reported. Similarly, no recognizable lead investors, significant portfolio companies, or prominent customers are publicly associated with GSM Fund. The organization's founding year and the names of its founders are also not publicly available, making it impossible to construct a complete profile consistent with standard industry reporting formats like those found on Bloomberg Terminal or PitchBook.
GSM Fund has 2 tracked investments across 1 company. The latest tracked deal is $40.0M Series E in Elcelyx Therapeutics in September 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2015 | Elcelyx Therapeutics | $40.0M Series E | James Xiaodong LIU | Advanced Technology Ventures, Longwood Fund, Morgenthaler Ventures, The Column Group, Kleiner Perkins, Morgenthaler Ventures, Technology Partners |
| Feb 14, 2013 | Elcelyx Therapeutics | $20.0M Series C | GSM Fund | Kleiner Perkins, Morgenthaler Ventures, Technology Partners |